Certara Services Archives

On-Demand Webinar

Bridging the Gap: Integrating Pharmacometrics with Quantitative Systems Pharmacology (QSP) for Smoother Clinical Phase Transitions

Master clinical phase transitions with insights from industry leaders! Join Piet van der Graaf, SVP…

CertaraJanuary 2, 2024

Press Coverage

Modeling and simulation in pediatric drug development

Published: December 21, 2023 This is the article written in German, published on pharmind. Children's…

CertaraDecember 21, 2023

Case Study

Accelerating a drug launch with value communication technology and an integrated workflow

With early approvals for a targeted cancer drug in Brazil and Argentina, this global pharmaceutical…

CertaraOctober 2, 2023

Case Study

Using customer engagement technology to create value communication tools for ABILIFY MAINTENA® (aripiprazole)

Otsuka identified several weaknesses in their existing workflow for developing value communication tools. In particular,…

CertaraOctober 2, 2023

White Paper

ICER’s Unsupported Price Increase Report: Unfit for Policymaking

Since 2019, the Institute for Clinical and Economic Review (ICER) has published an annual Unsupported…

CertaraJuly 25, 2023

Case Study

Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…

CertaraJune 1, 2023

Conference

American College of Toxicology 2025 Annual Meeting

– – Booth

CertaraMay 24, 2023

Conference

ISPOR Europe 2025

–

CertaraMay 24, 2023

Conference

ACoP 2025

CertaraMay 24, 2023

Case Study

Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease

RedHill Biopharma Ltd., a specialty biopharmaceutical company, developed RHB-204, a treatment for MAC, and needed…

CertaraMay 9, 2023

Certara Services

Bridging the Gap: Integrating Pharmacometrics with Quantitative Systems Pharmacology (QSP) for Smoother Clinical Phase Transitions

Modeling and simulation in pediatric drug development

Accelerating a drug launch with value communication technology and an integrated workflow

Using customer engagement technology to create value communication tools for ABILIFY MAINTENA® (aripiprazole)

ICER’s Unsupported Price Increase Report: Unfit for Policymaking

Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

American College of Toxicology 2025 Annual Meeting

ISPOR Europe 2025

ACoP 2025

Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease

Newsletter sign up

Quick links

Solutions

Contact